Results 71 to 80 of about 2,590,210 (272)

Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population‐based cohort study

Acta Obstetricia et Gynecologica Scandinavica, 2022
Introduction Epithelial ovarian cancer (EOC) patients undergoing splenectomy during cytoreductive surgery represent a small subgroup of patients. Splenic metastases or technical reasons due to extensive upper abdominal disease may require a splenectomy ...
Sherin A. Said, Maaike A. van derAa, Guus Veldmate, Joanne A. deHullu, Anne M. vanAltena   +4 more
doaj   +1 more source

Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial

BJU International, 2021
To analyse if exposure to sunitinib in the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial, which investigated opposite sequences of cytoreductive nephrectomy (CN) and systemic ...
Y. Abu-Ghanem, J. V. Thienen, C. Blank, M. Aarts, M. Jewett, Igle Jan Jong, J. Lattouf, H. Melick, L. Wood, P. Mulders, S. Rottey, J. Wagstaff, P. Zondervan, T. Powles, A. Neven, L. Collette, B. Tombal, J. Haanen, A. Bex   +18 more
semanticscholar   +1 more source

The Diagnostic Value of Confocal Laser Endomicroscopy in Brain Tumours When Performed by Blinded, Untrained Neuropathologists

Neuropathology and Applied Neurobiology, Volume 52, Issue 1, February 2026.
ABSTRACT Aim Achieving maximal and safe tumour resection is a key goal in brain tumour surgery. Confocal laser endomicroscopy (CLE) enables real‐time visualisation of the tissue microstructure at a cellular level, potentially helping neurosurgeons distinguish non‐neoplastic from neoplastic tissue.
Ilona Iff, Marielena Gutt‐Will, Theoni Maragkou, Andrea Mathis, Kathleen Seidel, David Capper, Elisabeth G. Hain, Jenny Meinhardt, Regina Von Manitius, Carsten Dittmayer, Simone Schmid, Ekkehard Hewer, Andreas Raabe, Philippe Schucht   +13 more
wiley   +1 more source

Cytoreductive Surgery for Advanced Ovarian Cancer [PDF]

Women's Health, 2014
The amount of the largest diameter of visible residual tumor after cytoreductive surgery remains one of the strongest prognostic factors In advanced ovarian cancer. The Implementation of a more aggressive surgical approach to Increase the proportion of patients without visible residual tumor Is, therefore, a rational concept.
Martin, Pölcher, Oliver, Zivanovic, Dennis S, Chi   +2 more
openaire   +2 more sources

Indications for Surgical Resection in Patients With Neuroendocrine Tumor Liver Metastases: An Intensive Surgical Experience of a High‐Volume Center

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 219-228, January 2026.
In patients with NELM, those with < 8 liver metastases and G1/2 tumors are the favorable candidates for liver resection. The important point of this study is that the patients who do not meet the above criteria should be considered for multidisciplinary treatment because of their extremely shorter recurrence‐free period.
Daisuke Asano, Toshitaka Sugawara, Keiichi Akahoshi, Shotaro Gan, Shohei Motohashi, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Atsushi Kudo, Daisuke Ban   +9 more
wiley   +1 more source

Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India

Gynecologic Oncology Reports
Introduction: Ovarian cancer is a disease that presents in advanced stage, due to the absence of any specific or overtly dramatic symptoms. The standard of care is primary debulking surgery, followed by chemotherapy.
Priya Bhati, Anitha Thomas, Rachel George Chandy, Amrita Datta, Dhanya Susan Thomas, Vinotha Thomas, Abraham Peedicayil, Ajit Sebastian   +7 more
doaj   +1 more source

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer

Prostate International, 2019
Background: Preclinical and retrospective data suggest that cytoreductive radical prostatectomy may benefit a subset of men who present with metastatic prostate cancer (mPCa).
Bertram E. Yuh, Young Suk Kwon, Brian M. Shinder, Eric A. Singer, Thomas L. Jang, Sinae Kim, Mark N. Stein, Tina Mayer, Anna Ferrari, Nara Lee, Rahul R. Parikh, Nora Ruel, Wun-Jae Kim, Shigeo Horie, Seok-Soo Byun, Thomas E. Ahlering, Isaac Yi Kim   +16 more
doaj   +1 more source

Long‐term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma

BJUI Compass, Volume 7, Issue 1, January 2026.
Abstract Objectives To assess treatment outcomes and evaluate patient selection criteria for cytoreductive partial nephrectomy (CRPN) in a unique cohort of metastatic renal cell carcinoma (mRCC) patients. Methods A retrospective review of mRCC patients who underwent CRPN between 1995 and 2023 at a single institution was performed.
Andrea Lopez Sanmiguel, Yash S. Khandwala, Emily A. Vertosick, Daniel Barbakoff, Roya Ghavamian, Jonathan A. Coleman, Mark Dawidek, Andrew J. Vickers, A. Ari Hakimi, Paul Russo   +9 more
wiley   +1 more source

CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI

Сибирский онкологический журнал, 2019
Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis accompanied by accumulation of mucus and high recurrence rate and in some cases complicated with intestinal obstruction.
A. G. Abdullaev, М. M. Davydov, N. A. Коzlov   +2 more
doaj   +1 more source

Combined and expanded operations in patients with relapsed ovarian cancer and affected retroperitoneal lymph nodes

Тазовая хирургия и онкология, 2020
Objective: to analyze short-term and long-term outcomes of expanded surgeries in patients with recurrent ovarian cancer and to identify factors affecting their overall survival (OS) and progression-free survival (PFS). Materials and methods.
Kh. I. Mamazhonov, S. O. Nikogosyan, V. V. Kuznetsov, A. S. Shevchuk, O. A. Egenov   +4 more
doaj   +1 more source